An antagonist of cADP-ribose inhibits arrhythmogenic oscillations of intracellular Ca2+ in heart cells - PubMed (original) (raw)
. 1999 Jun 18;274(25):17820-7.
doi: 10.1074/jbc.274.25.17820.
Affiliations
- PMID: 10364226
- DOI: 10.1074/jbc.274.25.17820
Free article
An antagonist of cADP-ribose inhibits arrhythmogenic oscillations of intracellular Ca2+ in heart cells
S Rakovic et al. J Biol Chem. 1999.
Free article
Abstract
Oscillations of Ca2+ in heart cells are a major underlying cause of important cardiac arrhythmias, and it is known that Ca2+-induced release of Ca2+ from intracellular stores (the sarcoplasmic reticulum) is fundamental to the generation of such oscillations. There is now evidence that cADP-ribose may be an endogenous regulator of the Ca2+ release channel of the sarcoplasmic reticulum (the ryanodine receptor), raising the possibility that cADP-ribose may influence arrhythmogenic mechanisms in the heart. 8-Amino-cADP-ribose, an antagonist of cADP-ribose, suppressed oscillatory activity associated with overloading of intracellular Ca2+ stores in cardiac myocytes exposed to high doses of the beta-adrenoreceptor agonist isoproterenol or the Na+/K+-ATPase inhibitor ouabain. The oscillations suppressed by 8-amino-cADP-ribose included intracellular Ca2+ waves, spontaneous action potentials, after-depolarizations, and transient inward currents. Another antagonist of cADP-ribose, 8-bromo-cADP-ribose, was also effective in suppressing isoproterenol-induced oscillatory activity. Furthermore, in the presence of ouabain under conditions in which there was no arrhythmogenesis, exogenous cADP-ribose was found to be capable of triggering spontaneous contractile and electrical activity. Because enzymatic machinery for regulating the cytosolic cADP-ribose concentration is present within the cell, we propose that 8-amino-cADP-ribose and 8-bromo-cADP-ribose suppress cytosolic Ca2+ oscillations by antagonism of endogenous cADP-ribose, which sensitizes the Ca2+ release channels of the sarcoplasmic reticulum to Ca2+.
Similar articles
- Nitric oxide inhibits Ca(2+) mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells.
Yu JZ, Zhang DX, Zou AP, Campbell WB, Li PL. Yu JZ, et al. Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H873-81. doi: 10.1152/ajpheart.2000.279.3.H873. Am J Physiol Heart Circ Physiol. 2000. PMID: 10993745 - cADP-ribose potentiates cytosolic Ca2+ elevation and Ca2+ entry via L-type voltage-activated Ca2+ channels in NG108-15 neuronal cells.
Hashii M, Minabe Y, Higashida H. Hashii M, et al. Biochem J. 2000 Jan 15;345 Pt 2(Pt 2):207-15. Biochem J. 2000. PMID: 10620496 Free PMC article. - Effects of photoreleased cADP-ribose on calcium transients and calcium sparks in myocytes isolated from guinea-pig and rat ventricle.
Cui Y, Galione A, Terrar DA. Cui Y, et al. Biochem J. 1999 Sep 1;342 ( Pt 2)(Pt 2):269-73. Biochem J. 1999. PMID: 10455010 Free PMC article. - [ADP-ribose and cADP-ribose--endogenous regulators of cellular ionic balance. Cardiotropic effects of ADP-ribose].
Kuz'min VS, Sosulina LIu, Sukhova GS, Ashmarin IP. Kuz'min VS, et al. Usp Fiziol Nauk. 2006 Jan-Mar;37(1):3-17. Usp Fiziol Nauk. 2006. PMID: 16522000 Review. Russian. - Cyclic ADP-ribose, the ryanodine receptor and Ca2+ release.
Sitsapesan R, McGarry SJ, Williams AJ. Sitsapesan R, et al. Trends Pharmacol Sci. 1995 Nov;16(11):386-91. doi: 10.1016/s0165-6147(00)89080-x. Trends Pharmacol Sci. 1995. PMID: 8578608 Review.
Cited by
- A network-based modeling framework reveals the core signal transduction network underlying high carbon dioxide-induced stomatal closure in guard cells.
Gan X, Sengottaiyan P, Park KH, Assmann SM, Albert R. Gan X, et al. PLoS Biol. 2024 May 1;22(5):e3002592. doi: 10.1371/journal.pbio.3002592. eCollection 2024 May. PLoS Biol. 2024. PMID: 38691548 Free PMC article. - Timing mechanisms to control heart rhythm and initiate arrhythmias: roles for intracellular organelles, signalling pathways and subsarcolemmal Ca2.
Terrar DA. Terrar DA. Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220170. doi: 10.1098/rstb.2022.0170. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122228 Free PMC article. Review. - CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.
de Zélicourt A, Fayssoil A, Dakouane-Giudicelli M, De Jesus I, Karoui A, Zarrouki F, Lefebvre F, Mansart A, Launay JM, Piquereau J, Tarragó MG, Bonay M, Forand A, Moog S, Piétri-Rouxel F, Brisebard E, Chini CCS, Kashyap S, Fogarty MJ, Sieck GC, Mericskay M, Chini EN, Gomez AM, Cancela JM, de la Porte S. de Zélicourt A, et al. EMBO Mol Med. 2022 May 9;14(5):e12860. doi: 10.15252/emmm.202012860. Epub 2022 Mar 17. EMBO Mol Med. 2022. PMID: 35298089 Free PMC article. - Na+/Ca2+ exchanger isoform 1 takes part to the Ca2+-related prosurvival pathway of SOD1 in primary motor neurons exposed to beta-methylamino-L-alanine.
Petrozziello T, Boscia F, Tedeschi V, Pannaccione A, de Rosa V, Corvino A, Severino B, Annunziato L, Secondo A. Petrozziello T, et al. Cell Commun Signal. 2022 Jan 12;20(1):8. doi: 10.1186/s12964-021-00813-z. Cell Commun Signal. 2022. PMID: 35022040 Free PMC article. - NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death.
Xu W, Li L, Zhang L. Xu W, et al. Front Physiol. 2020 Aug 13;11:901. doi: 10.3389/fphys.2020.00901. eCollection 2020. Front Physiol. 2020. PMID: 32903597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous